Evidence map›Paper›PMID 41128015›Full record

ArticleIntegrative cancer therapies

Therapeutic Yoga Enhances Neuroplasticity and Metabolic Regulation Through Elevated Plasma Brain-Derived Neurotrophic Factor (BDNF) and Ghrelin in a Heterogeneous Cancer Survivor Population.

Minal A Sonawane, Alice K Lee, Sagar Gaikwad, Gustavo J Almeida, Nydia T Darby, Tim Calderon, Amelie G Ramirez, Daniel C Hughes, Darpan I Patel

Abstract read
In one paragraph

Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Minal A SonawaneUniversity of Texas Medical Branch, Galveston, TX, USA.ORCID 0009-0008-3879-2839
Alice K LeeUniversity of Texas Medical Branch, Galveston, TX, USA.
Sagar GaikwadUniversity of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0003-2040-1357
Gustavo J AlmeidaUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Nydia T DarbyThe Open Hand Institute, San Antonio, TX, USA.
Tim CalderonUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Amelie G RamirezUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Daniel C HughesUniversity of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Darpan I PatelUniversity of Texas Medical Branch, Galveston, TX, USA.ORCID 0000-0001-8124-8072

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
NORTH AND CENTRAL TEXAS CTSA FOR PEDIATRIC RESEARCHUL1RR024982 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2007 to 2011
$27.9M
NCI NIH HHS P30 CA054174NCRR NIH HHS UL1 RR024982
6 · The paper itself

Abstract

backgroundCancer-related cognitive impairment (CRCI) frequently arises as a consequence of cancer treatments, manifesting in challenges such as impaired memory, attention, processing speed, and word finding. These cognitive deficits ranging from mild to moderate, can persist for months or even years. They can negatively impact a survivor's quality of life (QOL), mental health, and interpersonal relationships. Moreover, cancer and its therapies adversely affect various metabolic processes in the body influencing factors such as weight changes, fat metabolism, energy regulation, dyslipidemia, growth hormone regulation, and cardiovascular health. A secondary analysis was conducted to investigate whether a 16-week therapeutic yoga program (TYP) modulates the cognitive and metabolic biomarkers profile in plasma among heterogeneous cancer survivors. APPROACH: Participants included in the study were adults aged 18 years and older with a clinical cancer diagnosis. Informed consent was obtained from all participants. Nineteen participants completed 3 weekly 75-minute sessions of TYP combined with love and kindness meditation. Blood samples were collected from 16 participants both before and after the TYP intervention. Eight neurological, metabolic, and inflammatory biomarkers (β-NGF, BDNF, Ghrelin, IL12P70, Leptin, MCP-1, TNF-β, VEGF-A) were measured by a U-Plex Custom Metabolic Group1 (hu) Multiplex Assay on the MESO Quickplex SQ 120MM, Model 1300. Data was analyzed using the Wilcoxon signed-rank test.

resultsThe participants had a mean age of 59.6 years (±7.3). Over half of the cohort (56%) were classified as overweight or obese (BMI ≥ 25 kg/m²). The majority were female (71%) and breast cancer survivors (65%), with 44% of these survivors being of Hispanic ethnicity. Statistically significant increases were observed in the concentrations of brain-derived neurotrophic factor (BDNF; pre: 653.50 vs post: 1234.17 pg/ml; 88.85% increase,

conclusionTYP contributed to substantial improvements in plasma levels of BDNF and ghrelin in this heterogeneous cohort of cancer survivors. Future research involving larger cohorts is needed to validate these findings.

Indexed as

Brain-Derived Neurotrophic FactorCancer SurvivorsGhrelinNeoplasmsNeuronal PlasticityYogaAdultAgedBiomarkersCognitive DysfunctionFemaleHumansMaleMeditationMiddle AgedQuality of LifeBDNF protein, humanBiomarkersBrain-Derived Neurotrophic FactorGhrelincognitive impairmentmetabolic biomarkerstherapeutic yoga protocol

Identifiers

PMID41128015
PMCPMC12559641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.